Theravance Biopharma, Inc. (TBPH)
17.01
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
17.00
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma 1 Year Total Returns (Daily) : 22.29% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 22.29% |
| August 21, 2026 | 24.52% |
| August 20, 2026 | 26.59% |
| August 19, 2026 | 26.32% |
| August 18, 2026 | 24.54% |
| August 17, 2026 | 28.67% |
| August 14, 2026 | 31.14% |
| August 13, 2026 | 36.23% |
| August 12, 2026 | 41.95% |
| August 11, 2026 | 48.42% |
| August 10, 2026 | 46.79% |
| August 07, 2026 | 51.03% |
| August 06, 2026 | 51.34% |
| August 05, 2026 | 52.39% |
| August 04, 2026 | 50.45% |
| August 03, 2026 | 54.77% |
| July 31, 2026 | 51.08% |
| July 30, 2026 | 52.21% |
| July 29, 2026 | 52.77% |
| July 28, 2026 | 52.71% |
| July 27, 2026 | 52.86% |
| July 24, 2026 | 51.48% |
| July 23, 2026 | 49.20% |
| July 22, 2026 | 49.69% |
| July 21, 2026 | 48.37% |
| Date | Value |
|---|---|
| July 20, 2026 | 49.42% |
| July 17, 2026 | 45.70% |
| July 16, 2026 | 45.67% |
| July 15, 2026 | 46.83% |
| July 14, 2026 | 47.52% |
| July 13, 2026 | 49.56% |
| July 10, 2026 | 47.73% |
| July 09, 2026 | 46.51% |
| July 08, 2026 | 51.52% |
| July 07, 2026 | 50.40% |
| July 06, 2026 | 52.47% |
| July 02, 2026 | 53.21% |
| July 01, 2026 | 55.64% |
| June 30, 2026 | 54.13% |
| June 29, 2026 | 52.05% |
| June 26, 2026 | 64.31% |
| June 25, 2026 | 64.37% |
| June 24, 2026 | 61.86% |
| June 23, 2026 | 60.55% |
| June 22, 2026 | 55.79% |
| June 18, 2026 | 56.12% |
| June 17, 2026 | 57.64% |
| June 16, 2026 | 55.26% |
| June 15, 2026 | 52.67% |
| June 12, 2026 | 56.83% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Zymeworks, Inc. | 90.53% |
| Viatris, Inc. | 60.71% |
| Ocular Therapeutix, Inc. | -12.36% |
| ANI Pharmaceuticals, Inc. | -18.50% |
| Corcept Therapeutics, Inc. | 75.23% |